Risk staging with prophylactic unilateral central neck dissection in low-risk papillary thyroid carcinoma

医学 甲状腺癌 解剖(医学) 颈淋巴结清扫术 甲状腺 淋巴结 原发性肿瘤 回顾性队列研究 甲状腺切除术 病态的 放射科 外科 内科学 转移 癌症
作者
Dana M. Hartl,Abir Al Ghuzlan,S. Bidault,Ingrid Breuskin,Joanne Guerlain,Elizabeth Girard,Éric Baudin,Livia Lamartina,Julien Hadoux
出处
期刊:Ejso [Elsevier BV]
卷期号:49 (3): 568-574 被引量:2
标识
DOI:10.1016/j.ejso.2022.11.007
摘要

Current guidelines favor thyroid lobectomy for intrathyroidal cT1bT2cN0 papillary thyroid carcinoma. Prophylactic neck dissection (PND) is not recommended for these low-risk tumors due to the lack of high-level evidence on improvement in outcomes, but the information from PND may be used for staging. The aim of this study was to evaluate the rate of upstaging with ipsilateral PND.Retrospective study of patients with intrathyroidal unifocal cT1bT2cN0 papillary thyroid carcinoma from 2008 to 2021. All patients underwent total thyroidectomy and PND. Tumors were classified as low or intermediate risk based on the information from pathological analysis of the primary tumor and then from adding the analysis of the lymph nodes. The difference between the tumor-only and the PND-added risk staging was evaluated.Three hundred three patients (241 women, median age 45, median tumor size 17 mm) were included. Microscopic extrathyroidal extension was found in 23.4%, aggressive histology in 6.6%, vascular invasion in 29.3%, and lymph node metastases in 37.3%. One hundred ten patients (36.3%) were intermediate-risk based on the primary tumor. An additional 26 (8.6%) were upstaged to intermediate-risk based on the ipsilateral PND and 2% based on the contralateral PND. Kaplan-Meier 10-year event-free survival in tumors upstaged with ipsilateral PND was not statistically different from intermediate-risk tumors based on the primary tumor characteristics (92% versus 90.9%, Log Rank p = 0.943).Ipsilateral PND upstaged low-risk cT1bT2cN0 patients to intermediate risk in only 8.6% of cases, and contralateral PND in an additional 2%. Routinely performing PND may not be warranted.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
cdercder应助枝桠采纳,获得10
1秒前
苗条伟帮完成签到,获得积分10
4秒前
兴奋一斩完成签到,获得积分10
6秒前
7秒前
GUAGUA完成签到,获得积分20
8秒前
qianqiu完成签到 ,获得积分10
9秒前
eric完成签到,获得积分10
10秒前
隐形的邦布完成签到,获得积分10
11秒前
瘦瘦的枫叶完成签到 ,获得积分10
12秒前
罗健完成签到 ,获得积分10
12秒前
乘风破浪发布了新的文献求助10
13秒前
13秒前
14秒前
15秒前
17秒前
科研通AI2S应助sdl采纳,获得10
17秒前
神客发布了新的文献求助10
18秒前
枝桠完成签到,获得积分10
19秒前
西瓜发布了新的文献求助10
20秒前
0168先生发布了新的文献求助10
23秒前
思源应助善良的诗珊采纳,获得10
25秒前
Persevere完成签到,获得积分10
27秒前
爆米花应助神客采纳,获得10
28秒前
pluto应助看不完了采纳,获得10
28秒前
长情箴完成签到 ,获得积分10
29秒前
努力完成签到 ,获得积分10
29秒前
30秒前
Luxuehua完成签到,获得积分10
32秒前
34秒前
littlesun完成签到,获得积分20
34秒前
石龙子完成签到,获得积分10
35秒前
sdl发布了新的文献求助10
35秒前
神客完成签到,获得积分10
36秒前
chaogeshiren完成签到,获得积分10
38秒前
Luxuehua发布了新的文献求助10
38秒前
0168先生完成签到,获得积分10
39秒前
科研通AI5应助littlesun采纳,获得10
41秒前
看不完了完成签到,获得积分10
45秒前
俏皮的山水完成签到,获得积分10
47秒前
49秒前
高分求助中
【此为提示信息,请勿应助】请按要求发布求助,避免被关 20000
ISCN 2024 – An International System for Human Cytogenomic Nomenclature (2024) 3000
Continuum Thermodynamics and Material Modelling 2000
Encyclopedia of Geology (2nd Edition) 2000
105th Edition CRC Handbook of Chemistry and Physics 1600
Izeltabart tapatansine - AdisInsight 800
Maneuvering of a Damaged Navy Combatant 650
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3774441
求助须知:如何正确求助?哪些是违规求助? 3320155
关于积分的说明 10198712
捐赠科研通 3034786
什么是DOI,文献DOI怎么找? 1665211
邀请新用户注册赠送积分活动 796703
科研通“疑难数据库(出版商)”最低求助积分说明 757552